Poehling Capital Management, INC.
Source: SEC Form 13F · as of Mar 2026Poehling Capital Management, INC. holds 13 biotech & pharma companies tracked by BioSniper, totaling $24.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$24.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Viatris Inc (VTRS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| VTRSViatris Inc | 674,632 | $9.1M |
| JAZZJazz Pharmaceuticals plc | 22,639 | $4.3M |
| BMYBRISTOL MYERS SQUIBB CO | 53,711 | $3.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,151 | $2.5M |
| JNJJOHNSON & JOHNSON | 5,835 | $1.4M |
| OGNOrganon & Co. | 219,288 | $1.3M |
| PFEPFIZER INC | 37,537 | $1.1M |
| ABBVAbbVie Inc. | 2,807 | $610K |
| BHCBausch Health Companies Inc. | 85,604 | $462K |
| PMPhilip Morris International Inc | 1,555 | $257K |
| BIIBBIOGEN INC. | 1,144 | $210K |
| GERNGERON CORP | 76,201 | $114K |
| FEEDENvue Medical Inc. | 10,000 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.